Valladolid: Site Capabilities Overview

Curia’s site in Valladolid, Spain is a center of excellence for the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. The facility specializes in chemical synthesis across multiple stages of development, supporting projects from early clinical supply through to commercial-scale production.

Equipped with modern laboratories and GMP-compliant manufacturing suites, the site offers robust process development, optimization, and scale-up capabilities. Its technical teams are experienced in handling complex synthetic routes, ensuring high quality, reproducibility, and regulatory alignment throughout the product lifecycle.

In addition to API and intermediate manufacturing, the Valladolid facility provides sterile processing capabilities, including aseptic filtration for products requiring high levels of sterility assurance. This integrated offering enables seamless transition from synthesis to sterile finishing, reducing technology transfer complexity and streamlining supply chains.

Backed by strong regulatory expertise and a track record of global inspections, the Valladolid site delivers reliable, compliant solutions for pharmaceutical partners seeking end-to-end development and manufacturing support.